Today, I'd like to provide an update on the coronavirus, including the economic and market implications. We’ve had good news on the medical front, as the fourth wave of the virus doesn’t seem to be gaining traction. Case counts and positive test rates are back to the lows we saw as the third wave subsided, and hospitalizations and death rates have improved. One potential problem is that vaccination rates have slowed, which we will need to keep an eye on.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, we’ve seen modest deterioration over the past two weeks. Case counts and positive test rates have risen steadily, while hospitalizations and death rates have stabilized or increased by less than case growth. But with vaccinations continuing at an accelerating pace—the trend is now at more than 3.3 million per day—the race between vaccinations and the virus continues.

In March, we saw a strong end to a healthy first quarter for stock markets. Both the Dow and S&P 500 here in the U.S. showed gains, while developed markets abroad showed lower but still positive returns. We also had good news on the economic front. Hiring rebounded, layoffs dropped, and consumer confidence rose to post-pandemic highs.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. After several weeks of improvement on the medical front, we’re starting to see modest deterioration as the country reopens. Case counts and positive test rates are back to early March levels, while hospitalizations and death rates have stabilized. While the short-term risks are real, we do have a better outlook for the next two to three months. At that point, between vaccinations and existing exposure, we should be at or close to herd immunity.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. The medical situation continues to improve, as the vaccination campaign moves forward. Still, case growth remains above the levels seen between the second and third waves, and positive rates have not improved in weeks. We still have a very real pandemic on our hands.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, the stats have been getting better for the past two months, with case growth and hospitalizations down. That’s the good news. The bad news is that we are now at levels we saw at the peak of the second wave. And with some states starting to reopen and ending mandatory mask wearing, there are real things to worry about in the months ahead.

Markets climbed in February, although they faced some turbulence on a spike in interest rates. While markets were choppy, the medical news improved. New cases and hospitalizations dropped, and vaccinations more than doubled. On the economic front, unemployment remains high, but companies are hiring again. Plus, stimulus payments hit bank accounts, and consumer confidence is moving up.

Today I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, we appear to be well past the peak of the third wave, with daily infection rates and hospitalizations down. A more contagious variant of the virus could start another wave of infections, although there are no signs of that happening yet.

Today, I'd like to provide an update on the coronavirus, including the economic and market implications. On the medical front, new daily infection rates and hospitalizations were down, and we saw improvement in positive testing rates. Although the threat of a more contagious variant of the virus remains, substantial progress on vaccinations should help offset that risk.

Most developed markets were down slightly in January, including the Dow and S&P 500 in the U.S., as well as developed markets abroad. Despite the month's weak numbers, markets remain near all-time highs. On the economic front, layoffs were high and retail spending dropped. But with federal stimulus payments, consumer confidence has begun to recover, boosting higher-frequency spending data.